![Psound Bytes artwork](https://is1-ssl.mzstatic.com/image/thumb/Podcasts113/v4/19/58/65/1958656c-513e-a1d1-ac80-4ab7d381756a/mza_9152729259213470699.png/100x100bb.jpg)
Ep. 182 "The Ins and Outs of JAK Inhibitors for Psoriatic Disease"
Psound Bytes
English - December 06, 2022 11:30 - 20 minutes - 28.3 MB - ★★★★★ - 36 ratingsMedicine Health & Fitness Education healthandwellness arthritis chronicillness npf psoriasis psoriatic psound skin skincondition Homepage Download Apple Podcasts Google Podcasts Overcast Castro Pocket Casts RSS feed
Previous Episode: Ep. 181 "The Latest News in Topicals for Psoriasis"
Next Episode: Ep. 183 "What is Erythrodermic Psoriasis?"
Have questions about JAK inhibitors? Not sure how they work, what they treat, risks and how effective they are compared to other treatments? Listen as rheumatologist and NPF Medical Board member, Dr. Sergio Schwartzman from Weill Cornell Medical Center in NY, addresses such questions and more about the JAK STAT pathway. This Psound Bytes episode is provided with support from AbbVie, Amgen, Bristol Myers Squibb and Janssen.